← Back to all trials
Recruiting
NCT05642793
Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients
Conditions: Proliferative Diabetic Retinopathy
Sex: All
Ages: 19 Years – 70 Years
Phase: PHASE2
Enrollment: 80
Sponsor: Peking University Third Hospital
Location: China
Summary
This is an unmasking randomized clinical trial.
the main purpose of this study is to analyze whether posvitrectomy proactive use of conbercept can reduce the rate of postoperative complication in PDR patients.
Eligibility Criteria
Inclusion Criteria:PDR patients undergoing vitrectomyExclusion Criteria:patients who had received intravitreal injection or systemic use of all types of anti-VEGF agents in the recent three months before vitrectomypatients who had received intravitreal injection or systemic use of all types of steroid in the recent one month before vitrectomypatients who had received complete PRP before vitrectomypatients who are pregnant
Source: ClinicalTrials.gov (NCT05642793). StuddyBuddy aggregates publicly available trial information.